Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03127982
Other study ID # COLCIENCIAS 644-2014
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 1, 2015
Est. completion date December 20, 2021

Study information

Verified date November 2022
Source University of Los Andes, Columbia
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The present study aims at evaluating the effects of a CBT intervention, a cultural adaptation of the Unified Protocol for the Trans-diagnostic Treatment of Emotional Disorders (UP) in victims of the Colombian armed conflict. A randomized clinical trial aimed at evaluating the effects of the UP in a group of 100 internally displaced victims of armed conflict living in Bogotá is being implemented. Participants are recruited from several governmental, non-governmental agencies as well as community organizations of victims. Participants are being randomly assigned to treatment condition (N=50) or to waiting-list control (N=50). Treatment consists in 12 biweekly sessions covering the 8 modules of the original UP. The effects of the UP is evaluated through Patient Health Questionnaire (PHQ) and several measures of co-morbid emotional disorders, Anxiety, Depression, PTSD as well as level of functioning and quality of life.


Description:

Specific objectives - To translate and adapt the UP, taking into account the cultural, social, economic and political context of individuals exposed to political violence in Colombia. - Develop and adapt a set of assessment tools to identify victim's symptoms of anxiety, depression, and related disorders. - Conduct a randomized clinical trial comparing outcomes of 12 biweekly sessions of the culturally adapted UP in a group participants randomized to immediate treatment to a waiting list control receiving delayed (6-week) treatment. - To identify potential variables that mediate or moderate the effects of treatment with the UP. Methodology Design. Allocation randomized Participants. 100 individuals presenting emotional sequelae of exposure to violent events of armed conflict in Colombia, 50 of which are being randomly assigned to treatment group and 50 to control group (waiting list).


Recruitment information / eligibility

Status Completed
Enrollment 109
Est. completion date December 20, 2021
Est. primary completion date December 20, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Inclusion criteria. Individuals registered as victims in Colombian Victims Unit, 18 years or older, who meet the diagnostic criteria for one or more anxiety disorder(s), depressive disorder(s) or post-traumatic stress and related disorder(s) according to the Diagnostic and Statistical Manual (DSM-5, 2013) as determined by the International Neuro-Psychiatric Interview M.I.N.I. Exclusion Criteria: - Exclusion criteria. Individuals diagnosed with psychotic disorders, bipolar affective disorders, intellectual disability, dementia, substance abuse (as primary diagnoses, with hospitalization requirement for treatment) as well as individuals who endorse acute suicidal risk. Those that do not meet the inclusion criteria, but are in need of mental health attention, will be referred to entities of the Health System, so that they receive the pertinent treatment.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Unified Protocol
The Unified Protocol (UP) is a trans-diagnostic cognitive-behavioral therapy (tCBT) for individuals diagnosed with anxiety disorders, depression and related disorders (which we refer to as emotional disorders).

Locations

Country Name City State
Colombia Laboratorio de Psicología Clínica Uniandes - Universidad de Los Andes Bogotá DC

Sponsors (1)

Lead Sponsor Collaborator
University of Los Andes, Columbia

Country where clinical trial is conducted

Colombia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in diagnostic criteria for depression, anxiety, as assessed by the Patient Health Questionnaire. PHQ - complete. Administered at baseline, post-treatment - on average 8 weeks after the beginning of treatment, and a 3-month follow-up.
Primary Change in symptoms of post-traumatic stress as measured by the Post-Traumatic Stress Disorder (PTSD) Checklist for the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) (PCL-5). Administered at baseline, post-treatment - on average 8 weeks after the beginning of treatment, and a 3-month follow-up.
Secondary Quality of Life. Self-reported measure assessing the physical health, subjective feelings, leisure activities, social relationships, general activities, satisfaction with medications and life satisfaction. Quality of Life Enjoyment Questionnaire, Q-LES-Q. Administered at baseline, post-treatment - on average 8 weeks after the beginning of treatment, and a 3-month follow-up.
Secondary Anxiety measure. Overall Anxiety Severity and Impairment Scale (OASIS) Administered at baseline, post-treatment - on average 8 weeks after the beginning of treatment, and a 3-month follow-up.
Secondary Depression measure. Overall Depression Severity and Impairment Scale. (ODSIS). Administered at baseline, post-treatment - on average 8 weeks after the beginning of treatment, and a 3-month follow-up.
Secondary Current level of functioning. Current level of functioning measure. Adapted from ACOPLE. (Santaella-Tenorio J, Bonilla- Escobar FJ, Fandiño-Losada A, Bass J, Gutiérrez-Martínez MI, Bolton P. Validating an Instrument for victims of violence in Colombia: Evaluation of Two Community-based Mental Health Interventions for Violence-Displaced Afro-Descendants in Colombia. [Unpublished manuscript]. Colombia: University of Valle, Instituto CISALVA; 2013). -[Time Frame: Baseline, and 3-month follow-up. Baseline, and 3-month follow-up.
See also
  Status Clinical Trial Phase
Recruiting NCT04680611 - Severe Asthma, MepolizumaB and Affect: SAMBA Study
Active, not recruiting NCT04935593 - Strengthening Social, Emotional and Behavioral Resilience N/A
Not yet recruiting NCT05225701 - Efficacy of a Transdiagnostic Guided Internet-Delivered Intervention for Emotional, Trauma and Stress-Related Disorders. N/A
Recruiting NCT05172427 - Acceptability/Feasibility of IU Intervention N/A
Recruiting NCT03064477 - The Unified Protocol for the Treatment of Emotional Disorders in Spanish Public Mental Health System N/A
Recruiting NCT05019053 - Acceptability/Feasibility of COVID-19 Intervention N/A
Active, not recruiting NCT04847310 - Cost-benefit Evaluation of a Transdiagnostic Psychological Treatment for Emotional Disorders in Primary Care N/A
Completed NCT04091633 - School Health Implementation Network: Eastern Mediterranean N/A
Not yet recruiting NCT06056232 - Mechanisms of Mindfulness Intervention: Distress Tolerance Dose Manipulation N/A
Recruiting NCT06105567 - The Effect of Education Given According to the Health Promotion Model on Premenstrual Symptoms, Emotional Eating Behavior and Perceived Stress N/A
Recruiting NCT06373484 - Matching Assessment and Treatment for Children With Disruptive Behaviour and Their Parents N/A
Completed NCT05589090 - Super Skills for Life Effectiveness in the Online Modality N/A
Completed NCT03315208 - Study of a Transdiagnostic, Emotion-focused Group Intervention for Young Adults With Substance Use Disorders N/A
Completed NCT03312673 - Asthma, Smoking, Emotional Deficits
Completed NCT04182061 - Internet Transdiagnostic-CBT for Anxiety and Depression in Adolescents N/A
Not yet recruiting NCT05081830 - Online Transdiagnostic Intervention for Emotional Disorders and Stress-related Disorders N/A
Completed NCT04137471 - Validation of the Ontological Addiction Scale
Completed NCT05482724 - Super Skills for Life Effectiveness in Clinical Settings N/A
Terminated NCT03904784 - School Withdrawal in Adolescents
Recruiting NCT06361667 - Culture and Well-being: Art as Prescription Therapy ("Art on Prescription") N/A